Pharmacy

Below are 10 legal actions involving members of the drug supply chain, including pharmaceutical manufacturers, pharmacy benefit managers, pharmacies, pharmacists and distributors, reported by Becker's Hospital Review in the last two weeks.

Johnson & Johnson and Roche are forecasted to be the top spenders on research and development in 2024, according to a new report by Evaluate Pharma.

Premier Pharmacy Labs is recalling all its unexpired, sterile drugs after an FDA inspection raised questions about their sterility.

A federal judge has barred a former CVS Caremark executive from working at PillPack, the online pharmacy acquired by Amazon last year, according to legal news site Law 360.

Valisure, an online pharmacy licensed in 37 states, told the FDA it found another cancer-causing chemical in valsartan, a widely prescribed heart drug, according to Bloomberg.

CognitiveRx, a supply chain solution co-developed with Pittsburgh-based UPMC has launched. It helps predict, manage and solve challenges related to drug shortages, inflation and declining reimbursements.

Errant Gene Therapeutics, a biotech company based in Chicago, is suing a venture capital firm and BlueBird Bio's CEO, claiming the two parties worked to 'kill' a competing medical treatment, according to The Boston Business Journal.

Vertex's triple combination therapy for cystic fibrosis tops Evaluate Pharma's list of most valuable late-stage projects in the pharmaceutical industry pipeline.

In an effort to reduce provider burden and improve patient access to medication, CMS has issued a proposed rule to update e-prescribing standards, the agency announced June 17.

Rite Aid has partnered with Adobe to help drive Rite Aid's digital transformation, the drugstore chain announced June 17.